Leppäniemi Ari, Kimball Edward J, De Laet Inneke, Malbrain Manu L N G, Balogh Zsolt J, De Waele Jan J
Meilahti hospital, Abdominal Center, University of Helsinki, Finland.
Anaesthesiol Intensive Ther. 2015;47(4):400-8. doi: 10.5603/AIT.a2015.0026. Epub 2015 May 14.
The abdomen is the second most common source of sepsis and secondary peritonitis. The most common causes of abdominal sepsis are perforation, ischemic necrosis or penetrating injury to the abdominal viscera. Management consists of control of the infection source, restoration of gastrointestinal tract (GI) function, systemic antimicrobial therapy and support of organ function. Mortality after secondary peritonitis is still high. Excluding patient-related factors such as age or co-morbidities that can not be influenced at the time of intervention, delay to surgical intervention and inability to obtain source control are the main determinants of outcome. In patients with severe physiological derangement or difficult intraperitoneal conditions, where a prolonged operation and complete anatomical repair may not be possible or appropriate, it is becoming increasingly popular to utilize a damage control strategy with abbreviated laparotomy and planned reoperations. The main components of damage control laparotomy for secondary peritonitis are postponing the reconstruction of intestinal anastomoses to a second operation (deferred anastomosis) and leaving the abdomen open with some form of temporary abdominal closure (TAC). Advances in the management techniques of the open abdomen and new negative pressure-based TAC-devices have significantly reduced the previously observed prohibitive morbidity associated with open abdomens. These advancements have led to current fascial closure rates after TAC approaching 90%. The cornerstones of appropriate antimicrobial therapy are the timing, spectrum and dosing of antibiotics. Enteral nutrition should be started as soon as possible in hemodynamically stable patients but withheld when the patient is on a significant dose of vasopressors or whenever GI hypoperfusion is suspected. Timely source control with appropriate use of antimicrobial agents and early intensive care offers the best chance of survival for patients with abdominal sepsis. The introduction of the concept of damage control to the management of secondary peritonitis represents a paradigm shift in the same way as in management of major trauma. Although limited and repeated surgical interventions have been shown to be safe, the actual benefits need to be demonstrated in controlled studies.
腹部是脓毒症和继发性腹膜炎的第二大常见来源。腹部脓毒症最常见的病因是穿孔、缺血性坏死或腹部脏器穿透伤。治疗包括控制感染源、恢复胃肠道功能、全身抗菌治疗以及支持器官功能。继发性腹膜炎后的死亡率仍然很高。排除干预时无法影响的患者相关因素,如年龄或合并症,手术干预延迟和无法实现感染源控制是预后的主要决定因素。对于生理紊乱严重或腹腔内情况复杂的患者,延长手术时间和进行完整的解剖修复可能不可行或不合适,采用简化剖腹术和计划性再次手术的损伤控制策略越来越普遍。继发性腹膜炎损伤控制剖腹术的主要组成部分是将肠吻合重建推迟到第二次手术(延期吻合),并采用某种形式的临时腹部关闭(TAC)使腹部敞开。开放腹部管理技术的进步和新型基于负压的TAC装置显著降低了以前观察到的与开放腹部相关的高发病率。这些进展使TAC后目前的筋膜关闭率接近90%。恰当抗菌治疗的基石是抗生素的使用时机、抗菌谱和剂量。血流动力学稳定的患者应尽快开始肠内营养,但当患者使用大剂量血管升压药或怀疑存在胃肠道低灌注时应暂停。通过合理使用抗菌药物及时控制感染源并早期进行重症监护为腹部脓毒症患者提供了最佳生存机会。将损伤控制概念引入继发性腹膜炎的治疗与重大创伤治疗一样代表了一种范式转变。尽管有限且重复的手术干预已被证明是安全的,但实际益处仍需在对照研究中得到证实。